Description
Bivatuzumab (Anti-CD44 Recombinant Antibody; BIWA 4) is a humanized monoclonal antibody directed against CD44v6. CD44v6 could acts as a sarcoma target for CAR-redirected CIK cells.
Cat.No
A776
Name
Bivatuzumab
Chemical Properties
CAS
214559-60-1
Synonyms
Immunoglobulin G 1 (human-mouse monoclonal BIWA4 gamma1-chain antihuman antigen CD44v8), disulfide with human-mouse monoclonal BIWA4 gamma-chain, dimer;Research Grade Bivatuzumab(DHD14801);Bivatuzumab (anti-CD44v6);BIWA 4
pH value
Corresponds to reference standard: PASS
Non-reduced CE-SDS
>95%
SEC-HPLC
>95%
Isoelectric Point
Corresponds to reference standard
Bacterial Endotoxins Test
Residual Proteins of Host Cell
Exogenous Residual DNA
Residual protein A
Biological Activity
Osmolality
Corresponds to reference standard: PASS
Peptide mapping
Corresponds to reference standard: PASS
N-terminal sequence
Corresponds to reference standard: PASS
References
Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
Tel: +86-21-58447131Fax: +86-21-61642470Email:
Website:
